Inactive Instrument

Other languages AbbVie Euronext Paris

Equities

ABBV

US00287Y1091

Other languages

Unlock all the news: Be the first to know and act before the market!

AbbVie Says Arthritis Treatment Rinvoq Now Available for Certain Pediatric Patients in US	07:33pm
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	31/05
AbbVie Receives European Medicine Agency Committee's Recommendation for Approval of Severe Bowel Disease Drug Candidate	31/05
AbbVie Receives Positive CHMP Opinion for Risankizumab for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	31/05
OSE Immuno : vers une évolution de conseil d'administration	30/05
AbbVie Completes Acquisition of Landos Biopharma	24/05
Les entreprises dans le monde continuent de verser toujours plus de dividendes	23/05
AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders.	23/05
Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug	22/05
Fonds Small & Midcaps : Poursuite du rattrapage des petites cap’	18/05
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Walmart, Netflix, Abbvie, Delta...	17/05
En Direct des Marchés : Engie, Alstom, Vinci, ADP, Scor, Richemont, Carmat...	17/05
Borsa di Italia: La Cina resta divisa	17/05
In diretta dai mercati: Amplifon, ABB, Snam, Salcef, Saipem, Properties, DiaSorin, Tesla, HSBC, Renault, Prosus, Qualcomm, GSK...	17/05
Bolsa de Madrid: China sigue dividida	17/05
La Chine toujours tiraillée	17/05
Medincell : recul du titre après une étude clinique décevante	15/05
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders	13/05
Medincell : le titre grimpe pour sa reprise de cotation	09/05
AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine	08/05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AbbVie Euronext Paris

Equities

ABBV

US00287Y1091

Other languages

Filters